Source: Basic and Clinical Pharmacology and toxicology. Unidade: FMRP
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA RENAL CRÔNICA, METALOPROTEINASES, UREMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARSON, Bernardo P. e FIGUEIREDO, Carlos E. Poli de e SANTOS, José Eduardo Tanus dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, v. 110, n. 5, p. 409-415, 2012Tradução . . Disponível em: https://doi.org/10.1111/j.1742-7843.2012.00863.x. Acesso em: 04 nov. 2024.APA
Marson, B. P., Figueiredo, C. E. P. de, & Santos, J. E. T. dos. (2012). Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target. Basic and Clinical Pharmacology and toxicology, 110( 5), 409-415. doi:10.1111/j.1742-7843.2012.00863.xNLM
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00863.xVancouver
Marson BP, Figueiredo CEP de, Santos JET dos. Imbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological target [Internet]. Basic and Clinical Pharmacology and toxicology. 2012 ; 110( 5): 409-415.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1111/j.1742-7843.2012.00863.x
